NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Thermaquil Inc.

Thermaquil Inc.

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://www.thermaquil.com/

Last Round

Grant

Jan 4, 2021

Total Funding Raised

$4.55M

Company Overview

Thermaquil Inc. is a medical device company and manufacturer of a reversible device intended to block overactive nerves without relying on drugs, electrical stimulation, or causing nerve damage.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Health IoT

Business Model

B2G

Customer Profile

Government Contracts, Hardware Sales

AI Layer

Non-AI

Keywords

thermal neuromodulationreversible nerve blockdrug-free pain reliefpain management deviceneuromodulation deviceopioid alternativebioelectronic medicinechronic pain managementwearable medical devicenon-invasive medical devicemigraine treatmentDARPA contractorminimally invasive deviceelectroceuticalsbladder function restorationSBIR grant

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Thermaquil Inc. Comparables

Compare Thermaquil Inc. with similar companies based on industry and business-model similarity.

Thermaquil Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Thermaquil Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 4, 2021
View all Funding Rounds

Thermaquil Inc. Investors

Notable investors and investment history

Thermaquil Inc. investors
InvestorRounds
U.S. Department of Health and Human ServicesGrant
NIH RADxGrant
Pitt Innovation ChallengeAccelerator
Defense Advanced Research Projects AgencyGrant
National Science FoundationGrant
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 4, 2021

    $1M grant awarded by the National Science Foundation.

View all signals

Thermaquil Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Thermaquil Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Thermaquil Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range2
Year Founded2017
Last FundingJan 4, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.